financetom
Business
financetom
/
Business
/
ED Director Sanjay Kumar Mishra's tenure ends, Rahul Navin appointed in-charge chief
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ED Director Sanjay Kumar Mishra's tenure ends, Rahul Navin appointed in-charge chief
Sep 15, 2023 2:42 PM

IRS officer Rahul Navin was appointed as in-charge director of the Enforcement Directorate on Friday on the completion of tenure of the incumbent Sanjay Kumar Mishra, officials said.

According to an official order, Navin, a 1993-batch IRS officer, will hold the charge till the appointment of a regular director or until further orders. Navin is currently the ED’s special director.

The order stated that the President "is pleased to order the cessation of tenure of Sanjay Kumar Mishra…as Director of Enforcement in the Enforcement Directorate on 15.09.2023." On July 26, the Supreme Court granted an extension of tenure to ED chief Mishra till September 15 but made it clear there would be no further extension.

The SC order came days after it had held as "illegal" two successive extensions of one year each granted to ED director Mishra, an IRS officer of 1984 cadre, saying these were in ”breach” of its mandamus in the 2021 verdict that the IRS officer should not be given further term.

The 1984-batch IRS officer was otherwise to remain in office till November 18, 2023, according to the notification issued by the government.

The verdict on a batch of petitions, including those filed by Congress leaders Randeep Singh Surjewala and Jaya Thakur, and TMC leaders Mahua Moitra and Saket Gokhale, challenging the extensions granted to Mishra.

Mishra was first appointed the ED director for two years on November 19, 2018. Later, by an order dated November 13, 2020, the central government modified the appointment letter retrospectively and his two-year term was changed to three years.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tarsus Pharmaceuticals Insider Sold Shares Worth $2,364,904, According to a Recent SEC Filing
Tarsus Pharmaceuticals Insider Sold Shares Worth $2,364,904, According to a Recent SEC Filing
Mar 20, 2026
04:32 AM EDT, 03/20/2026 (MT Newswires) -- Bobak R. Azamian, Director, President, Chief Executive Officer and Board Chair, on March 17, 2026, sold 34,603 shares in Tarsus Pharmaceuticals ( TARS ) for $2,364,904. Following the Form 4 filing with the SEC, Azamian has control over a total of 891,412 common shares of the company, with 33,421 shares held directly and...
Tarsus Pharmaceuticals Insider Sold Shares Worth $772,444, According to a Recent SEC Filing
Tarsus Pharmaceuticals Insider Sold Shares Worth $772,444, According to a Recent SEC Filing
Mar 20, 2026
04:30 AM EDT, 03/20/2026 (MT Newswires) -- Seshadri Neervannan, Chief Operating Officer, on March 17, 2026, sold 11,324 shares in Tarsus Pharmaceuticals ( TARS ) for $772,444. Following the Form 4 filing with the SEC, Neervannan has control over a total of 86,255 common shares of the company, with 85,780 shares held directly and 475 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1819790/000182758426000009/xslF345X05/wk-form4_1773961468.xml...
Telos Insider Sold Shares Worth $408,154, According to a Recent SEC Filing
Telos Insider Sold Shares Worth $408,154, According to a Recent SEC Filing
Mar 20, 2026
04:31 AM EDT, 03/20/2026 (MT Newswires) -- Edward Hutchinson Robbins Jr., Executive Vice President and General Counsel, on March 17, 2026, sold 101,623 shares in Telos ( TLS ) for $408,154. Following the Form 4 filing with the SEC, Robbins has control over a total of 583,183 common shares of the company, with 567,278 shares held directly and 15,905 controlled...
Tarsus Pharmaceuticals Insider Sold Shares Worth $439,566, According to a Recent SEC Filing
Tarsus Pharmaceuticals Insider Sold Shares Worth $439,566, According to a Recent SEC Filing
Mar 20, 2026
04:31 AM EDT, 03/20/2026 (MT Newswires) -- Jeffrey S Farrow, Chief Financial Officer and Chief Strategy Officer, on March 17, 2026, sold 6,430 shares in Tarsus Pharmaceuticals ( TARS ) for $439,566. Following the Form 4 filing with the SEC, Farrow has control over a total of 43,316 common shares of the company, with 43,316 shares held directly. SEC Filing:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved